OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gut microbiome and nonalcoholic fatty liver disease
Mengyuan Wu, Jian‐Gao Fan
Hepatobiliary & pancreatic diseases international (2023) Vol. 22, Iss. 5, pp. 444-451
Closed Access | Times Cited: 14
Mengyuan Wu, Jian‐Gao Fan
Hepatobiliary & pancreatic diseases international (2023) Vol. 22, Iss. 5, pp. 444-451
Closed Access | Times Cited: 14
Showing 14 citing articles:
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024)
Jian‐Gao Fan, Xiaoyuan Xu, Rui-Xu Yang, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 15
Jian‐Gao Fan, Xiaoyuan Xu, Rui-Xu Yang, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 15
Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3694-3694
Open Access | Times Cited: 12
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3694-3694
Open Access | Times Cited: 12
MetALD: Does it require a different therapeutic option?
George Marek, Harmeet Malhi
Hepatology (2024) Vol. 80, Iss. 6, pp. 1424-1440
Closed Access | Times Cited: 8
George Marek, Harmeet Malhi
Hepatology (2024) Vol. 80, Iss. 6, pp. 1424-1440
Closed Access | Times Cited: 8
Integrated multi-omic analysis identifies fatty acid binding protein 4 as a biomarker and therapeutic target of ischemia–reperfusion injury in steatotic liver transplantation
Mengfan Yang, Wenzhi Shu, Xiangyu Zhai, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 5
Mengfan Yang, Wenzhi Shu, Xiangyu Zhai, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 5
Gut Microbiome—How Does Two-Month Consumption of Fiber-Enriched Rolls Change Microbiome in Patients Suffering from MASLD?
Karolina Kaźmierczak-Siedlecka, Dominika Maciejewska, Maciej Sykulski, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1173-1173
Open Access | Times Cited: 5
Karolina Kaźmierczak-Siedlecka, Dominika Maciejewska, Maciej Sykulski, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1173-1173
Open Access | Times Cited: 5
The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies
Lijun Wang, Jian Sun, Shu Cheng Chen, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Lijun Wang, Jian Sun, Shu Cheng Chen, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Aurantio‐Obtusin Regulates Gut Microbiota and Serum Metabolism to Alleviate High‐Fat Diet‐Induced Obesity‐Associated Non‐Alcoholic Fatty Liver Disease in Mice
Zhen-Lin Li, Jin Yao, Hua-Shan Zhao, et al.
Phytotherapy Research (2025)
Closed Access
Zhen-Lin Li, Jin Yao, Hua-Shan Zhao, et al.
Phytotherapy Research (2025)
Closed Access
Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease
Lillian Du, Kaichuang Zhang, Lili Liang, et al.
mSystems (2025)
Open Access
Lillian Du, Kaichuang Zhang, Lili Liang, et al.
mSystems (2025)
Open Access
A study of correlation of the dietary index for gut microbiota with non-alcoholic fatty liver disease based on 2007–2018 National Health and Nutrition Examination Survey
Yinda Wang, Binzhong Zhang, Lianzhong Feng, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Yinda Wang, Binzhong Zhang, Lianzhong Feng, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer’s disease through machine learning algorithms
Liqing Jiang, Qian Wang, Yingsong Jiang, et al.
Clinica Chimica Acta (2024) Vol. 557, pp. 117892-117892
Open Access | Times Cited: 3
Liqing Jiang, Qian Wang, Yingsong Jiang, et al.
Clinica Chimica Acta (2024) Vol. 557, pp. 117892-117892
Open Access | Times Cited: 3
Exploring the therapeutic potential of silymarin-based herbal remedy (prebiotic) and probiotic blend in a mouse model of NAFLD: Insights into gut microbiota modulation and liver health
Tanya Ralli, Shahnawaz Ahmad, Zoya Saifi, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e33505-e33505
Open Access | Times Cited: 2
Tanya Ralli, Shahnawaz Ahmad, Zoya Saifi, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e33505-e33505
Open Access | Times Cited: 2
Evaluating the role of IER3+ macrophages in the prognosis of liver fibrosis by bulk and single-cell transcriptional analyses
Ling Chu, Junbo Zhang, R. L. Meng, et al.
iLiver (2024) Vol. 3, Iss. 4, pp. 100132-100132
Open Access
Ling Chu, Junbo Zhang, R. L. Meng, et al.
iLiver (2024) Vol. 3, Iss. 4, pp. 100132-100132
Open Access
Characterization of the hepatic flora and metabolome in nonalcoholic fatty liver disease
Hua Jiang, Hui Wang, Yisong Guo, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Hua Jiang, Hui Wang, Yisong Guo, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
The role of the gut microbiome in chronic liver diseases: Present insights and future outlook
Lu Jiang, Jian‐Gao Fan
Hepatobiliary & pancreatic diseases international (2023) Vol. 22, Iss. 5, pp. 441-443
Closed Access
Lu Jiang, Jian‐Gao Fan
Hepatobiliary & pancreatic diseases international (2023) Vol. 22, Iss. 5, pp. 441-443
Closed Access
